CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Review Supports Mandatory Testing of Aging Physicians

Published: Tue, 15 Aug 2017 19:17:17 EDT
Some health systems have started evaluations for those aged at least 70 years. Authors say that, if the medical community doesn't start giving this serious thought, legislatures may start setting the rules.
Medscape Medical News

AMA Releases MIPS Action Plan and Expanded Toolset

Published: Tue, 15 Aug 2017 18:25:24 EDT
The AMA has released part of a toolset that doctors can use to prepare their practices for MIPS or alternative payment models.
Medscape Medical News

Psychiatrist's Appointment as US 'Mental Health Czar' Praised

Published: Tue, 15 Aug 2017 16:48:44 EDT
Mental health organizations are applauding the US Senate's recent confirmation of psychiatrist Dr Elinore McCance-Katz as the first HHS assistant secretary for mental health and substance use.
Medscape Medical News
Displaying results 10-12 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Ophthotech completes clean sweep of phase 3 trial flops

Published: Mon, 14 Aug 2017 12:43:55 +0000
Ophthotech has posted negative results from a third phase 3 trial of its wet age-related macular degeneration (AMD) candidate.

CellAct punches above its weight with Mundipharma deal

Published: Mon, 14 Aug 2017 12:36:17 +0000
CellAct has brought its cancer drug CAP7.1 through to phase 2 testing with a little over $10 million in financing—and claimed the reward of a $250 million partnership with Mundipharma.

James Mullen backs Vicarius’ $22M series A to equip ex-Biogen, Elan team to offer U.S. biotechs a route to Europe

Published: Mon, 14 Aug 2017 09:09:15 +0000
James Mullen has teamed up with colleagues from his days leading Biogen to help U.S. biotechs bring drugs to market in Europe.
Displaying results 10-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top